(Q37717853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Mimi Lo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Christopher W Crank

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

23 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

Journal of Oncology Pharmacy Practice

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

147-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Advances in the management of malignancy-associated hyperuricaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Clarifying the role of rasburicase in tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155210364180

21 January 2018

Identifiers

DOI

10.1177/1078155210364180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20332174%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference